About Repligen (RGEN)
Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio ... Read more
- USD166.21
- USD168.10
- USD163.23
- USD211.13
- -15.20%
- 639M
- 98.44k
- 501.96k
- 8.8B
- 110.45
- -0.20%
- 115.20%
Stock News
4 hours ago
Vivid Seats Renews National Make-A-Wish® Partnership to Grant Live Event Experiences
Yahoo
4 hours ago
Partner base continues to grow: Greenman Energy opts for battery-buffered fast chargers from ADS-TEC Energy
Yahoo
4 hours ago
Redfin Reports Home Prices Stagnate in Florida and Texas as Supply Soars
Yahoo
4 hours ago
Leading Office Furniture Manufacturer Implements Bridgeline’s HawkSearch
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
